5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Supriya Lifescience Ltd.

•
supriyalifescience.comBSE: 543434NSE: SUPRIYA
Market Cap₹ 7,274 Cr.
Current Price
High / Low₹ 1,085 / 546
Stock P/E36.7
Book Value₹ 152
Price to Book3.80
Dividend Yield0.11 %
ROCE25.3 %
ROE19.1 %
Face Value₹ 2

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company is almost debt free
  • Company has a healthy return on capital (ROCE) of 25.1%
  • Operating margins have improved to 32.2% from 26.8%
  • Company has delivered good sales growth of 16.2% CAGR over last 5 years
  • Company generates healthy free cash flow
  • Company has a consistent dividend-paying track record

CONS

  • Receivables are growing faster than sales - a possible quality concern
  • Valuation is stretched - P/E of 36.7 is well above its own 5-year median (22.4)
  • Though reporting repeated profits, the company pays out little dividend (3.8%)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY MICROCAP250NIFTY TOTAL MKT
S.No.Name
1.SUNPHARMA1842.0036.54441957.500.872901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9326.0084.64247576.000.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4975.0086.76189233.010.76566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1119.5024.74111670.550.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1365.0032.72110272.680.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1970.3597.37106460.420.10362.07123.942026.3129.1018.2031.50
7.DRREDDY1161.0030.0796906.380.69435.60-69.108099.80-5.2113.7510.63
8.AUROPHARMA1675.4525.9796401.690.241032.0325.229150.3517.4412.7620.54
9.LUPIN2096.0017.3495842.920.861416.9816.018276.8934.2828.8629.59
10.MANKIND2277.0046.0494050.370.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2416.9037.9468210.880.10482.83927.884018.4831.3520.3520.03
12.SUPRIYA903.8536.677274.440.1124.04-30.89189.7530.8025.3025.01
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
132140140158161166186184145200206277190
88108991039810112011793127134179152
Operating Profit44324156636566685273729838
OPM %33.70%22.67%29.61%35.09%38.94%38.96%35.52%36.71%35.64%36.35%34.92%35.30%20.10%
3232232333233
Interest1001001010000
Depreciation4444555667789
Profit before Tax43304053606263644768679241
Tax %33.14%19.78%25.71%30.54%25.31%25.65%25.25%21.35%26.62%26.19%25.78%19.43%41.06%
Net Profit29243037454647503550507424
3.542.973.704.595.545.715.826.294.326.276.179.222.99

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
184213278312391530461570696828873
166191213213218316332395436533592
Operating Profit17226498173214128176261295280
OPM %9.33%10.31%23.19%31.57%44.26%40.37%27.87%30.81%37.46%35.63%32.15%
79811581011101111
Interest12111074435232
Depreciation55567101216202831
Profit before Tax8145796167207123166248275268
Tax %29.80%39.66%30.96%23.72%26.13%26.75%27.23%28.11%24.36%23.90%26.02%
Net Profit69397312415290119188209198
EPS3.871.195.3910.0316.8918.8611.1614.8023.3525.98—
Dividend Payout %0.00%0.00%0.00%19.94%3.20%3.18%5.37%5.41%4.28%3.85%—

COMPOUNDED SALES GROWTH

10 Years:
17%
5 Years:
16%
3 Years:
22%

COMPOUNDED PROFIT GROWTH

10 Years:
43%
5 Years:
11%
3 Years:
33%

STOCK PRICE CAGR

10 Years:
—
5 Years:
—
3 Years:
48%
1 Year:
38%

RETURN ON EQUITY

10 Years:
31%
5 Years:
21%
3 Years:
19%
Last Year:
19%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2026

Sep 4

₹ 0.50

Rs.1.0000 per share(50%)Final Dividend

2025

Sep 4

₹ 0.50

Rs.1.0000 per share(50%)Final Dividend

2024

Sep 20

₹ 0.40

Rs.0.8000 per share(40%)Final Dividend

2023

Sep 15

₹ 0.30

Rs.0.6000 per share(30%)Final Dividend

2022

Sep 1

₹ 0.30

Rs.0.6000 per share(30%)Final Dividend

2026

Aug 27

₹ 0.50

Rs.1.0000 per share(50%)Final Dividend

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital15151515151616161616
3140791352546006837999811,182
14012191100892722555
Trade Payables414244495149646075111
15282438374434444143
Total Liabilities2412452533364457358209241,1171,357
89918598100190262310453689
Capital Work in Progress3634354079436814914836
00000025646399
38323149729211685118160
0000000112134219
Cash & Bank632289228158757979
738510114710518119212912176
Total Assets2412452533364457358209241,1171,357

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
27316314310611094113165186
Cash from Investing-27-55-25-47-60-124-174-152-176
Cash from Financing-2-20-50-29-15150-10-22-8-10
-2346215139-70-834-0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
68.3068.3068.3068.3068.3068.3068.3068.3068.30
4.956.036.527.196.785.465.195.166.18
5.485.454.934.264.865.225.005.705.30
Government0.000.000.000.000.000.000.000.000.00
21.2720.2320.2620.2620.0621.0221.5020.8420.21

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-11
Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-11 - Supriya Lifescience Limited has informed the Exchange about Schedule of meet

2026-09-02
General Updates

2026-09-02 - Supriya Lifescience Limited has informed the Exchange about General Updates

2026-09-02
General Updates

2026-09-02 - Supriya Lifescience Limited has informed the Exchange about General Updates

2026-09-02
Copy of Newspaper Publication

2026-09-02 - Supriya Lifescience Limited has informed the Exchange about Copy of Newspaper Publication

2026-09-02
Clarification - Financial Results

2026-09-02 - The Exchange has sought clarification from Supriya Lifescience Limited for the quarter ended 30-Jun-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: The response of the Company is awaited.

2026-09-01
Shareholders meeting

2026-09-01 - Supriya Lifescience Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 24, 2026

2026-08-27
Copy of Newspaper Publication

2026-08-27 - Supriya Lifescience Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-26
Record Date

2026-08-26 - Supriya Lifescience Limited has informed the Exchange that Record date for the purpose of Dividend is 04-Sep-2026.

2026-08-22
Shareholders meeting

2026-08-22 - Supriya Lifescience Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.

News

Recent coverage and analyst commentary for SUPRIYA

Loading news…

🤖

AI Stock Analyst

Supriya Lifescience Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login